WuXi PharmaTech (Cayman) Inc. (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

WX 45.18 +2.01 (4.66%)
price chart
Skeptics Bank on a WuXi PharmaTech (Cayman) Inc. (WX) Pullback
WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is fresh off a seven-year high of $45 -- and was last seen 11.4% higher at $44 -- after the R&D firm announced it has received an offer to go private.
What's lifting these 3 stocks? - WuXi PharmaTech (Cayman) Inc. (ADR) (WX ...
Autohome Inc (ADR) (NYSE:ATHM) closed U.S. trading at $51.04, up +1.51 points or +3.05% from previous close. This company will report its financial results for the first quarter of 2015 before the U.S.
Healthcare Stocks Traders Alert-WuXi (Cayman) Inc. (ADR) (WX), Neurocrine ...  Techsonian (press release)
WuXi PharmaTech (Cayman)'s "Strong Sell" Rating Reiterated at ...  Mideast Time
WuXi PharmaTech (Cayman)'s Strong Sell Rating Reaffirmed at Zacks (WX)
WuXi PharmaTech (Cayman) Inc. logo Zacks reiterated their strong sell rating on shares of WuXi PharmaTech (Cayman) (NYSE:WX) in a research note released on Friday morning. Zacks' analyst wrote, �Shanghai-based WuXi PharmaTech is the leading ...
WuXi PharmaTech (Cayman)'s Strong Sell Rating Reiterated at Zacks (WX)  WKRB News
WuXi PharmaTech (Cayman) Stock Rating Reaffirmed by Zacks (WX)  The Legacy
Johnson & Johnson, WuXi PharmaTech (Cayman) Inc. (ADR): Aging Chinese ...
investing George Leong: China is dealing with an aging population. By 2030, the number of Chinese citizens 65 years or older is estimated to come in at a whopping 240 million, or about 18% of the current population.
WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) a Buy: Morgan Stanley
In a research note issued to investors, Bin Li at Morgan Stanley Reiterated their Buy rating on WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX). The analyst placed a $42.00 price target on the stock which indicates a 17.81% upside to the last closing price.
Hedge Funds Aren't Crazy About WuXi PharmaTech (Cayman) Inc. (ADR) (WX ...
Is WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) ready to rally soon? Prominent investors are taking a pessimistic view.
Related articles »  
Should You Buy WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX)? - Alere ...
WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) shareholders have witnessed an increase in enthusiasm from smart money of late.
Short Interest in WuXi PharmaTech (Cayman) Inc. Expands By 82.0% (WX)
Receive News & Ratings for WuXi PharmaTech (Cayman) Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi PharmaTech (Cayman) Inc. and related companies with Analyst Ratings ...
Upbeat Stocks- CST Brands, Inc. (NYSE:CST), WuXi PharmaTech (Cayman) Inc ...
CST Brands, Inc. (NYSE:CST) and CrossAmerica Partners LP (CAPL) reported that Joe Topper, the CEO and President of CrossAmerica, has decided to retire as CEO effective September 30, 2015.
Morgan Stanley Reiterates Overweight, Lowers PT On WuXi PharmaTech On ...
However, we remain positive on WX's long term prospects, given 1) solid growth in the core business; and 2) more upside in genomics and other B2C businesses with EPS accretion beginning in 2017.
WuXi PharmaTech (Cayman) Cut to Neutral at Goldman Sachs (WX)  The Legacy